English Norwegian

Topics

Published 06.02.2004 , updated 20.03.2009, 10:37

  • Autism is a disorder that particularly affects development of social interaction, language and communication. Present from birth, autism symptoms usually appear by the age of three. The NIPH is involved in a large research project with ColumbiaUniversity to investigate the causes of autism.
  • Biohealth Norway The biobank platform Biohealth Norway is a research collaboration established due to a substantial grant from the Norwegian Functional Genomics Research Program, FUGE,  for the years 2002-2007. The platform is hosted by the Norwegian Institute of Public Health in collaboration with the universities of Oslo, Bergen, Trondheim and Tromsø. Here is information about the other biobanks involving the Norwegian Institute of Public Health.
  • Diabetes is on the increase globally. It is estimated that 171 million people have the disease (WHO). By 2030, this number could be over twice as many - 366 million. On these pages you will find information about diabetes in Norway and news about research from the Norwegian Institute of Public Health.
  • Drinking water Drinking water means water for human consumption and hygiene, whether delivered from taps, tanks, bottles or other sources. All water for household use should be of the same quality as drinking water. NIPH provides advice on drinking water, water supply and recreational water to central, regional and local authorities plus owners of water works and public swimming pools.
  • Environmental Pollution The water we drink, the air we breathe and the food are essential for our survival. Therefore it is important that they do not contain hazardous substances that may cause health problems.
  • Influenza in Norway Influenza is an infectious disease that affects a large proportion of the population annually.  It is a major cause of acute illness and outbreaks often result in fatalities.  NIPH is responsible for monitoring influenza activity in Norway, enabling us to inform health and other authorities, as well as the public about the virus' progress.
  • Mental Health Our main research areas are causes and risk factors for mental disorders and psychological distress, suicide and suicide-related behaviour, research into prevention and how social inequality affects health.
  • Osteoporosis Osteoporosis is a medical condition which leads to reduced bone mass and brittle bones with an increased risk of fracture. It is estimated that between 96 000 and 225 000 Norwegian women have osteoporosis.
  • Pharmacoepidemiology Pharmaceutical drugs are the most common form of medical treatment in the Norwegian health service. In the course of a year, two-thirds of the Norwegian population will have been dispensed a prescribed drug. Research into drug consumption is a prioritised area for the Norwegian Institute of Public Health.
  • Vaccine Vaccines are the most effective agents for preventing infectious diseases. However, for optimal effect it they must be administered correctly at the right time to appropriate groups of the population. The Norwegian Institute of Public Health aims, through its expertise in this area, to ensure that vaccines used in Norway are as effective as possible.